Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine

European Journal of Neuroscience

Volumn 18, Issue 2, 2003, Pages 383-390

  Compan, V ^a,b   Scearce Levie, K ^a   Crosson, C ^c   Daszuta, A ^b   Hen, R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b CNRS   (France)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

5 HT1B receptor; Immunocytochemistry; Knockout mice; Naloxone; Open field

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; ENKEPHALIN DERIVATIVE; METENKEPHALIN; NALOXONE; OPIATE ANTAGONIST; SEROTONIN 1A AGONIST; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; EFFERENT NERVE; EXPLORATORY BEHAVIOR; GLOBUS PALLIDUS; IMMUNOCYTOCHEMISTRY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; STRIA TERMINALIS; SUBSTANTIA NIGRA; WILD TYPE;

ANIMALS; BLOTTING, NORTHERN; BRAIN; ENKEPHALINS; IMMUNOHISTOCHEMISTRY; INDOLES; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; SEROTONIN AGONISTS;

EID: 0041942680     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02767.x     Document Type: Article

References (64)

1. Anagnostakis, Y., Krikos, Y. & Spyraki, C. (1992) Pallidal substrate of morphine-induced locomotion. Eur. Neuropsychopharmacol., 1, 65-72.
2. Angulo, J.A. & McEwen, B.S. (1994) Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev., 19, 1-28.
3. Barden, N., Daigle, M., Picard, V. & Di Paolo, T. (1983) Perturbation of rat brain serotonergic systems results in an inverse relation between substance P and serotonin concentrations measured in discrete nuclei. J. Neurochem., 41, 834-840.
4. Becker, A., Grecksch, G., Brodemann, R., Kraus, J., Peters, B., Schroeder, H., Thiemann, W., Loh, H.H. & Hollt, V. (2000) Morphine self-administration in mu-opioid receptor-deficient mice. Naunyn Schmiedebergs Arch. Pharmacol., 361, 584-589.
5. Bengel, D., Murphy, D.L., Andrews, A.M., Feltner, D. & Heils, A. (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-N-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice. Mol. Pharmacol., 53, 649-655.
6. 1B receptor is localized predominantly on axon terminals. Neuroscience., 58, 167-182.
7. Bourgoin, S., Artaud, F., Cesselin, F., Glowinski, J. & Hamon, M. (1985) Local and remote effects of intra-caudate administration of GABA-related drugs on Met-enkephalin release in the basal ganglia. Brain Res., 1-2, 361-372.
8. 1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine. Neuropsychopharmacology, 7, 113-127.
9. Chalmers D.T & Watson S.J. (1991) Comparative anatomical distribution of 5-HT receptor mRNA binding in rat brain - a combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res., 561, 51-60.
10. Chaouloff, F., Courvoisier, H., Moisan, M.P. & Mormède, P. (1999) GR 127935 reduces basal locomotor activity and prevents RU 24969, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat. Psychopharmacology, 141, 3326-3331.
11. 1B receptor. Br. J. Pharmacol., 110-114, 1621-1629.
12. 4 receptors in the rat basal ganglia and hippocampus. Eur. J. Neuroscience., 8, 2591-2598.
13. Compan, V., Salin, P. & Daszuta, A. (1997) Selective effects of partial and severe lesions of the serotonergic systems on met-enkephalin and substance P neurons in rat basal ganglia. Mol. Brain Res., 50, 246-256.
14. 2 serotonin receptors in the rat basal ganglia. Brain Res., 793 (1-2), 103-111.
15. Dellavedova, L., Parenti, M., Tirone, F. & Groppetti, A. (1982) Interactions between serotonergic and enkephalinergic neurons in rat striatum and hypothalamus. Eur. J. Pharmacol., 85, 29-34.
16. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press Inc, New York, NY, USA.
17. Geyer, M.A. & Callaway, C.W. (1994) Behavioral pharmacology of ring-substituted amphetamine analogs. In Cho, A.R & Segal, O.S. (eds), Amphetamine and its Analogs. Academic Press, New York, pp. 177-201.
18. Gold, L.H., Koob, G.F. & Geyer, M.A. (1988) Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxymethamphetamine in rats. J. Pharm. Exp. Therapeutics., 247, 547-555.
19. Graybiel, A.M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci., 13, 44-254.
20. Grung, M., Skurtveit, S., Aasmundstad, T.A., Handal, M., Alkana, R.L. & Morland, J. (1998) Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors. J. Pharmacol. Toxicol., 82-1, 3-10.
21. 1 receptors. Neuropsychopharmacology, 3, 349-360.
22. Hanson, G.R., Singh, N., Bush, L. & Gibb, J.W. (1991) Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine. J. Pharmacol. Exp. Ther., 259, 1197-1202.
23. Hebb, M.O. & Robertson, H.A. (2000) Identification of a subpopulation of substantia nigra pars compacta gamma-aminobutyric acid neurons that is regulated by basal ganglia activity. J. Comp Neurol., 416, 30-44.
24. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena & Humphrey, P.P. (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
25. Hoyer, D. & Middlemiss, D.N. (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci., 10, 130-132.
26. Hurd, Y.L. & Herkenham, M. (1992) Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res. Mol. Brain Res., 16, 97-104.
27. B synaptic potential in rat dopamine neurons. J. Neurosci., 12, 2000-2006.
28. Joyce, E.M., Koob, G.F., Strecker, R., Iversen, S.D. & Bloom, F.E. (1981) The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus. Brain Res., 221, 359-370.
29. Koch, S. & Galloway, M.P. (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J. Neural. Transm., 104, 135-146.
30. Krause, J.E., Chirgwin, J.M., Carter, M.S., Xu, Z.S. & Hershey, A.D. (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl Acad. Sci. USA, 84, 881-885.
31. Kuzmin, A., Sandin, J., Terenius, L. & Ögren, S.-O. (2000) Dose- and time-dependant bimodal effects of k-opioid agonists on locomotor activity in mice. J. Pharmacol. Exp Ther., 295, 1031-1042.
32. Li, S.J., Jiang, H.K., Stachowiak, M.S., Hudson, P.M., Owyang, V., Nanry, K., Tilson, H.A. & Hong, J.S. (1990) Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Brain Res. Mol. Brain Res., 8, 219-225.
33. McKenna, D.J. & Peroutka, S.J. (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). J. Neurochem., 54-1, 4-22.
34. Mendella, P.D. & Zacharko, R.M. (1996) Variations of motor activity following intraventricular (D-Pen2, D-Pen5)enkephalin administration: interaction with acute uncontrollable foot-shock in mice. Pharmacol. Biochem. Behav., 53, 877-883.
35. Michael-Titus, A., Dourmap, N., Caline, H., Costentin, J. & Schwartz, J.C. (1989) Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J). Neuropharmacology, 28, 117-122.
36. Mickley, G.A., Mulvihill, M.A. & Postler, M.A. (1990) Brain mu and delta opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse. Psychopharmacology, 101, 332-337.
37. 1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology., 98, 321-329.
38. Mochetti, I., Schwartz, J.P. & Costa, E. (1985) Use of mRNA hybridization and radioimmunoassay to study mechanisms of drug-induced accumulation of enkephalins in rat brain structures. Mol. Pharmacol., 28, 86-91.
39. Murray, C.W. & Cowan, A. (1990) [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice. Psychopharmacology, 102, 425-426.
40. Nisenbaum, L.K., Crowley, W.R. & Kitai, S.T. (1996) Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Mol. Brain Res., 37, 209-216.
41. Obradovic, T., Imel, K.M. & White, S.R. (1998) Repeated exposure to 3,4-methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin. Brain Res., 785, 1-9.
42. Parent, A. & Hazrati, L.N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev., 20, 91-127.
43. Phillips, T.J., Hen, R. & Crabbe, J.C. (1999) Complications associated with genetic background effects in research using knockout mice. Psychopharmacology, 147, 5-7.
44. 2C receptors. Mol. Brain Res., 23, 163-178.
45. 1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology, 8, 201-212.
46. Salin, P. & Chesselet, M.F. (1992) Paradoxical increase in striatal neuropeptide gene expression following ischemic lesions of the cerebral cortex. Proc. Natl Acad. Sci. USA, 89, 9954-9958.
47. 1B receptor. Science., 265, 1875-1878.
48. Saudou, F. & Hen, R. (1994) 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem. Int., 25, 503-532.
49. 1B receptor. Psychopharmacology, 141, 154-161.
50. Siegfried, B., Filibeck, U., Gozzo, S. & Castellano, C. (1982) Lack of morphine-induced hyperactivity in C57BL/6 mice following striatal kainic acid lesions. Behav. Brain Res., 4, 389-399.
51. Sora, I., Elmer, G., Funada, M., Pieper, J., Li, X.F., Hall, F.S. & Uhl, G.R. (2001) Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology, 25, 41-54.
52. 1A autoreceptors on serotonergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci., 2, 1144-1154.
53. Sprague, J.E., Everman, S.L. & Nichols, D.E. (1998) An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology, 3, 427-441.
54. Sprouse, J.S., Bradberry, C.W., Roth, R.H. & Aghajanian, G.K. (1989) MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Eur J. Pharmacol., 167, 375-383.
55. Steele, T.D., Nichols, D.E. & Yim, G.K. (1989) MDMA transiently alters biogenic amines and metabolites in mouse brain and heart. Pharmacol. Biochem. Behav., 34, 223-227.
56. Stevens, K.E., Mickley, G.A. & McDermott, L.J. (1986) Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse. Pharmacol. Biochem. Behav., 6, 1739-1747.
57. Tian, M., Broxmeyer, H.E., Fan, Y., Lai, Z., Zhang, S., Aronica, S., Cooper, S., Bigsby, R.M., Steinmetz, R., Engle, S.J., Mestek, A., Pollock, J.D., Lehman, M.N., Jansen, H.T., Ying, M., Stambrook, P.J., Tischfield, J.A. & L. (1997) Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J. Exp Med., 185, 1517-1522.
58. Van Der Kooy, D. & Hattori, T. (1980) Dorsal raphe nuclei with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res., 186, 1-7.
59. Van Praag, H. & Frenk, H. (1992) The effects of systemic morphine on behavior and EEG in newborn rats. Brain Res. Dev Brain Res., 67, 19-26.
60. 1 receptors subtypes in the brain of control and 5,7-dihydroxytryptamine-treated rats. J. Neurosci., 6, 3474-3482.
61. 6, with neuropeptides in rat striatum. J. Comp. Neurol., 370, 405-414.
62. Wichems, C.H., Hollingsworth, C.K. & Bennett, B.A. (1995) Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release. Brain Res., 695, 10-18.
63. Wing, L.L., Tapson, G.S. & Geyer, M.A. (1990) 5-HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology, 100, 417-425.
64. Yamamoto, B.K., Nash, J.F. & Gudelsky, G.A. (1995) Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J. Pharmacol. Exp. Ther., 273, 1063-1070.